Lineage Inc (LINE)

NASDAQReal EstateReit - IndustrialSnapshot 2026-10-23

$35.36+0.77%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Lineage Inc’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	1.36B
EPS	—	-0.198
Annual ending 2026-12-31
Revenue	—	5.39B
EPS	—	-0.746
Annual ending 2027-12-31
Revenue	—	5.53B
EPS	—	-0.58

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Achieve adjusted EBITDA of $1.25 to $1.30 billion in 2026	Lineage aims to deliver adjusted EBITDA near $1.25 billion in 2026.	Intact	adjusted EBITDA falls below $1.25 billion in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Full-year 2026 adjusted EBITDA guidance has been consistently maintained between $1.25 billion and $1.30 billion, with the latest range at $1.26 to $1.29 billion. Adjusted FFO per share guidance also remained stable at $2.75 to $3.05. The company reported revenues growing modestly from $1.297 billion in 2026-Q1 to $1.361 billion in 2026-Q2, with operating income improving from $36 million to $54 million, indicating progress aligned with the EBITDA guidance. The trajectory is delivering against this priority. Delivery assessment Oct 24, 2026
Maintain dividend per share at $0.53	It maintains a stable dividend of $0.53 per share.	Intact	dividend per share falls below $0.53 in FY26	Dividend per share: $0.53 per share FY2026-Q2; GAAP. Published target: >=0.53 USD_PER_SHARE. Target period is not explicitly aligned with this observation. Source published Aug 5, 20260.53 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: ed0ef7e7-fa26-4c55-82af-5ab8a199a047. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. The quarterly dividend per share has been consistently maintained around $0.53, with $0.5275 declared in 2025-Q3 and $0.5325 in 2026-Q2. This steady dividend payout aligns with management's commitment to shareholder returns. The trajectory is delivering. Delivery assessment Oct 24, 2026
Sustain revenue growth near 2% annually	A supporting condition in Lineage Inc's published investment case. The stated target is >=2% YoY.	Intact	revenue growth falls below 2% YoY next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS: comparable history unavailable.

FY2027 revenue$5.53B

$5.54B → $5.53B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	$5,539,318,184	3 / 8
2026-07-25	Unavailable	$5,539,318,184	3 / 8
2026-07-26	Unavailable	$5,544,684,940	1 / 10
2026-07-27	Unavailable	$5,531,791,669	3 / 8
2026-07-28	Unavailable	$5,531,791,669	3 / 8
2026-07-29	Unavailable	$5,531,791,669	3 / 8
2026-07-30	Unavailable	$5,535,225,002	3 / 8
2026-07-31	Unavailable	$5,535,225,002	3 / 8
2026-08-01	Unavailable	$5,535,225,002	3 / 8
2026-08-02	Unavailable	$5,535,225,002	3 / 8
2026-08-03	Unavailable	$5,548,804,940	1 / 10
2026-08-04	Unavailable	$5,548,804,940	1 / 10
2026-08-05	Unavailable	$5,535,225,002	3 / 8
2026-08-06	Unavailable	$5,535,225,002	3 / 8
2026-08-07	Unavailable	$5,549,783,335	3 / 8
2026-08-08	Unavailable	$5,549,783,335	3 / 8
2026-08-09	Unavailable	$5,558,931,760	1 / 11
2026-08-10	Unavailable	$5,558,931,760	1 / 11
2026-08-12	Unavailable	$5,549,783,335	3 / 8
2026-08-13	Unavailable	$5,558,931,760	2 / 11
2026-08-14	Unavailable	$5,549,783,335	3 / 8
2026-08-15	Unavailable	$5,549,783,335	4 / 8
2026-08-16	Unavailable	$5,549,783,335	4 / 8
2026-08-17	Unavailable	$5,549,783,335	4 / 8
2026-08-18	Unavailable	$5,549,783,335	4 / 8
2026-08-19	Unavailable	$5,549,783,335	4 / 8
2026-08-20	Unavailable	$5,508,895,724	4 / 9
2026-08-21	Unavailable	$5,508,895,724	4 / 9
2026-08-22	Unavailable	$5,508,895,724	4 / 9
2026-08-23	Unavailable	$5,508,895,724	4 / 9
2026-08-24	Unavailable	$5,508,895,724	4 / 9
2026-08-25	Unavailable	$5,508,408,926	4 / 9
2026-08-26	Unavailable	$5,508,408,926	4 / 9
2026-08-27	Unavailable	$5,508,408,926	4 / 9
2026-08-28	Unavailable	$5,508,408,926	4 / 9
2026-08-29	Unavailable	$5,508,408,926	4 / 9
2026-08-30	Unavailable	$5,508,408,926	4 / 9
2026-08-31	Unavailable	$5,508,408,926	4 / 9
2026-09-01	Unavailable	$5,508,408,926	4 / 9
2026-09-02	Unavailable	$5,523,672,563	4 / 9
2026-09-03	Unavailable	$5,523,672,563	4 / 9
2026-09-04	Unavailable	$5,523,672,563	4 / 9
2026-09-05	Unavailable	$5,523,672,563	4 / 9
2026-09-06	Unavailable	$5,523,672,563	4 / 9
2026-09-07	Unavailable	$5,523,672,563	4 / 9
2026-09-08	Unavailable	$5,523,672,563	4 / 9
2026-09-09	Unavailable	$5,521,781,144	4 / 9
2026-09-10	Unavailable	$5,521,781,144	3 / 9
2026-09-11	Unavailable	$5,519,417,507	3 / 9
2026-09-12	Unavailable	$5,519,417,507	3 / 9
2026-09-13	Unavailable	$5,519,417,507	3 / 9
2026-09-14	Unavailable	$5,519,417,507	3 / 9
2026-09-15	Unavailable	$5,519,417,507	3 / 9
2026-09-16	Unavailable	$5,519,417,507	4 / 9
2026-09-17	Unavailable	$5,519,417,507	4 / 9
2026-09-18	Unavailable	$5,519,417,507	4 / 9
2026-09-19	Unavailable	$5,519,417,507	4 / 9
2026-09-20	Unavailable	$5,519,383,871	4 / 9
2026-09-21	Unavailable	$5,519,383,871	4 / 9
2026-09-22	Unavailable	$5,519,383,871	4 / 9
2026-09-23	Unavailable	$5,519,383,871	4 / 9
2026-09-24	Unavailable	$5,519,383,871	4 / 9
2026-09-25	Unavailable	$5,519,383,871	4 / 9
2026-09-26	Unavailable	$5,519,383,871	4 / 9
2026-09-27	Unavailable	$5,519,383,871	4 / 9
2026-09-28	Unavailable	$5,519,383,871	4 / 9
2026-09-29	Unavailable	$5,518,100,326	4 / 9
2026-09-30	Unavailable	$5,518,100,326	4 / 9
2026-10-01	Unavailable	$5,507,909,417	4 / 9
2026-10-02	Unavailable	$5,507,909,417	4 / 9
2026-10-03	Unavailable	$5,507,909,417	4 / 9
2026-10-04	Unavailable	$5,507,909,417	4 / 9
2026-10-05	Unavailable	$5,507,909,417	4 / 9
2026-10-06	Unavailable	$5,507,909,417	4 / 9
2026-10-07	Unavailable	$5,507,909,417	4 / 9
2026-10-08	Unavailable	$5,507,909,417	4 / 9
2026-10-09	Unavailable	$5,507,909,417	4 / 9
2026-10-10	Unavailable	$5,507,909,417	4 / 9
2026-10-11	Unavailable	$5,507,909,417	4 / 9
2026-10-12	Unavailable	$5,507,909,417	4 / 9
2026-10-13	Unavailable	$5,507,909,417	4 / 9
2026-10-14	Unavailable	$5,507,909,417	4 / 9
2026-10-15	Unavailable	$5,507,909,417	4 / 9
2026-10-16	Unavailable	$5,507,909,417	4 / 9
2026-10-17	Unavailable	$5,507,909,417	4 / 9
2026-10-18	Unavailable	$5,507,909,417	4 / 9
2026-10-19	Unavailable	$5,507,909,417	4 / 9
2026-10-20	Unavailable	$5,507,909,417	4 / 9
2026-10-21	Unavailable	$5,507,909,417	4 / 9
2026-10-22	Unavailable	$5,528,469,720	4 / 9
2026-10-23	Unavailable	$5,528,469,720	4 / 9
2026-10-24	Unavailable	$5,528,469,720	4 / 9

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	5	11	4
2026-06-01	5	11	4
2026-07-01	6	11	4
2026-08-01	6	10	4
2026-09-01	7	10	4
2026-10-01	7	9	4

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 7 Buy / Strong Buy · 9 Hold · 4 Sell / Strong Sell

0 upgrades0 downgrades5 maintains

Recent actions · Sep 25–Oct 24 · 5 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

UBSOct 20 · prior Jul 17

$45.00 → $36.00-20.0%

Piper SandlerOct 12 · prior Aug 27

$44.00 → $36.00-18.2%

Evercore ISIOct 2 · prior Jun 8

$44.00 → $43.00-2.3%

$0$24.75$49.50

0 raises · 3 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Achieve adjusted EBITDA of $1.25 to $1.30 billion in 2026Direct metric needs a verified mapping
Maintain dividend per share at $0.53Dividend per share: $0.53 per share
Sustain revenue growth near 2% annuallyDirect metric needs a verified mapping

Next proof point

Nov 9, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.1%Typical daily move · historical

Downside history

-25.5%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Lineage Inc outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

LINE is a real estate operating company with a performance-driven, rate-sensitive thesis rather than a proven earnings compounder, since the evidence classifies earnings quality as loss-making. The 1 to 3 year thesis is intact, but its signal has shifted to mixed as company momentum weakened.

What's priced into Lineage Inc

The valuation evidence says LINE is cheap versus peers, while the expectations gap is slightly negative, suggesting expectations are not especially demanding. The priced-in assessment is tagged justified, with low fragility, though the valuation model’s confidence is high rather than a guarantee.

What the fundamentals likely do

Near term, revenue and operating income improved from the first quarter to the second quarter of 2026, and same-warehouse occupancy rose year over year. Management has maintained its 2026 adjusted EBITDA guidance and dividend level, but recent earnings surprises have been erratic and the company has a history of a deep miss.

What Lineage Inc hinges on

The multi-year view depends on LINE delivering its 2026 adjusted EBITDA guidance and continuing to improve occupancy. Near term, Fed rate cuts and continued strength from real estate peers would support the sector backdrop, while a guidance cut would be a meaningful negative.